BTIG Moves To Neutral On DexCom, But Says Shares Are Not Overvalued

By: via Benzinga
BTIG cut DexCom, Inc. (NASDAQ: DXCM) to Neutral from Buy, as the shares have reached its $92 price target. The firm added that the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.